EGFR: epidermal growth factor receptor; PORT: postoperative radiotherapy.
* In addition to radiation for positive margins, some UpToDate contributors also offer PORT to a subset of patients found to have N2 disease at surgery who have particularly high-risk features, as follows:However, other UpToDate contributors do not offer PORT to those with resected N2 disease, unless margins are positive.
¶ Although some UpToDate experts offer definitive chemoradiation to all treatment candidates with stage III N2 disease, others offer induction chemotherapy by surgery to a select subgroup with favorable features, ie, those with all of the following:Do you want to add Medilib to your home screen?